Original Webinar Date: 06/29/2021

Tumor-Normal Matched Sequencing and Platforms Utilized for Tumor Profiling

The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 2
Speakers Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine

ep2 onclive preview image

Mark Robson, MD, reviews data from a recent abstract on incidental germline findings detected by tumor-normal matched sequencing and the panelists share which platforms they utilize for tumor profiling.

Watch the Webinar Here

Resource Center

View more